Due to the role of leptin-mediated signaling in obesity-link cancer, several therapeutic agents have been designed to modulate the leptin cascade, such as leptin receptor and leptin antagonists35. The gene discussed is LEPR; the disease is obesity due to melanocortin 4 receptor deficiency.